Clinical Trial Update: Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing vaccination in patients with recurrent respiratory papillomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Papilloma of the Larynx

Snippet

Sponsor: Ruth Tachezy, PhD. | Conditions: Squamous Papilloma of the Larynx | Phase 3 | Status: COMPLETED